A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease
Clinical trial NCT06126783 · COMPLETED
Trial details
- NCT number
- NCT06126783
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2025-09-23
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.